4//SEC Filing
Newton Todd 4
Accession 0001251769-19-000068
CIK 0001251769other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 5:01 PM ET
Size
6.7 KB
Accession
0001251769-19-000068
Insider Transaction Report
Form 4
Newton Todd
DirectorChief Executive Officer
Transactions
- Purchase
6.0% Convertible Debentures due 2024
2019-08-12$400000.00/shExercise: $3.25From: 2019-08-12Exp: 2024-08-12→ Common Sock (123,077 underlying)
Footnotes (2)
- [F1]Pursuant to a securities purchase agreement (the "Purchase Agreement"), dated as of August 7, 2019, the Issuer issued and sold $20.0 million aggregate principal amount of 6.0% Convertible Debentures (the "Notes") to certain purchasers. The Notes are initially convertible into shares of the Issuer's common stock, par value $0.001 per share, subject to certain adjustments.
- [F2]Interest on the Notes is payable semi-annually in shares of the Issuer's common stock on January 1 and July 1 of each year, beginning on January 1, 2020, at a rate of 6.00% per year and based on the average volume-weighted average price, or VWAP, of the Issuer's common stock for the 10 consecutive trading days immediately preceding the applicable interest payment date. However, interest will be paid in-kind on such interest payments dates if (i) the average VWAP of the Issuer's common stock for the 10 consecutive trading days immediately preceding such interest payment date is less than $2.50 per share, or (ii) the Issuer fails to satisfy certain common stock delivery obligations upon conversion of the Notes.
Documents
Issuer
Apollo Endosurgery, Inc.
CIK 0001251769
Entity typeother
Related Parties
1- filerCIK 0001460878
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 5:01 PM ET
- Size
- 6.7 KB